Cargando…

Prevention of Hepatitis B Recurrence in Liver Transplant Patients Using Oral Antiviral Therapy without Long-Term Hepatitis B Immunoglobulin

BACKGROUND: Small studies have suggested that nucleos(t)ide analogue therapy (NAT) with reduced hepatitis B immunoglobulin (HBIG) duration may be efficacious in preventing post-liver transplantation (LT) HBV recurrence. OBJECTIVES: This larger study evaluates the use of NAT with short term (< 6 m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Joseph, Cohen, Stanley Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227486/ https://www.ncbi.nlm.nih.gov/pubmed/22140388 http://dx.doi.org/10.5812/kowsar.1735143X.717

Ejemplares similares

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: A meta‐analysis
por: Lai, Quirino, et al.
Publicado: (2021)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence
por: VATANSEVER, Sezgin, et al.
Publicado: (2019)

Long‐term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation
por: Vasudevan, Abhinav, et al.
Publicado: (2018)

Hepatitis B Vaccine and Immunoglobulin: Key Concepts
por: Das, Saibal, et al.
Publicado: (2019)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues
por: Schreibman, Ian R, et al.
Publicado: (2006)

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B
por: Choi, Ho Joong, et al.
Publicado: (2017)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017)

Systematic review: Clinical outcomes of discontinuation of oral antivirals in hepatitis B-related liver cirrhosis
por: Yao, Yuhao, et al.
Publicado: (2022)

Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure)
por: Ning, Qin, et al.
Publicado: (2019)

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression
por: Lee, Hankil, et al.
Publicado: (2021)

Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure
por: Lee, I-Cheng, et al.
Publicado: (2017)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
por: Rupp, Christian, et al.
Publicado: (2018)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Prophylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?
por: Harmancı, Özgür, et al.
Publicado: (2014)

Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
por: Volpes, Riccardo, et al.
Publicado: (2020)

Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B
por: Perrillo, Robert, et al.
Publicado: (2013)

Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation
por: Lou, Bin, et al.
Publicado: (2021)

Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels
por: Sinakos, Emmanouil, et al.
Publicado: (2016)

Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection
por: Lu, Lun-Gen
Publicado: (2014)

Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone
por: Li, Hao, et al.
Publicado: (2016)

Molecular Mechanisms to Control Post-Transplantation Hepatitis B Recurrence
por: Takaki, Akinobu, et al.
Publicado: (2015)

Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare
por: Quan, Min, et al.
Publicado: (2022)

Absence of Hepatitis B Resistance Mutants before Introduction of Oral Antiviral Therapy
por: Moehlen, Martin, et al.
Publicado: (2013)

Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature
por: Dehghani, Seyed Mohsen, et al.
Publicado: (2013)

Recurrence of hepatitis C after liver transplantation
por: Vinaixa, Carmen, et al.
Publicado: (2013)

De Novo Superinfection of Hepatitis B Virus in an Anti-HBs Positive Patient with Recurrent Hepatitis C Following Liver Transplantation
por: Ha, Sung-Hae, et al.
Publicado: (2011)

Assessment of histopathological alterations in patients with chronic hepatitis B infection following long-term oral antiviral therapy
por: Şahin, Ahmet, et al.
Publicado: (2018)

YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy
por: Rahimi, Rahim, et al.
Publicado: (2015)

Prevention and treatment of new hepatitis B after living donor liver transplantation in children
por: Li, Junjie, et al.
Publicado: (2021)

Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
por: Roche, Bruno, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_14q5qai30tmo4gib82mufahvf6